Yan Li, MD
Neurological Surgery · Syracuse, NYNPI 1932363843
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $6,844 of the $9,425 with a category attached, or 72.6%. Globus Medical accounts for 78.4% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $4,530 and has fallen 94.5% since, to $247 in 2025.
Across 58 payments — averaging $162.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$7K
- Si-bone, Inc.$646
- Providence Medical Technology, Inc.$496
- Medtronic$332
- Stryker$121
- Bayer$106
- plus $331 from 7 others
What the payments were for
- Travel & lodging$6,84473%
- Food & beverage$2,58127%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 19 | $7,394 |
| Si-bone, Inc. | 12 | $646 |
| Providence Medical Technology, Inc. | 7 | $496 |
| Medtronic(2 entities) | 5 | $332 |
| Stryker | 2 | $121 |
| Bayer | 1 | $106 |
| Boston Scientific | 2 | $78 |
| Spinal Elements, Inc. | 2 | $73 |
| GS Solutions, Inc. | 1 | $68 |
| Lilly USA, LLC | 3 | $44 |
| Boehringer Ingelheim | 2 | $35 |
| Baxter Healthcare | 1 | $20 |
| GSK | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RISE-L$2,672
- CALIBER$1,465
- Excelsius - GPS$1,054
- ELSA ATP$964
- ELSA$513
- Excelsius Robotics System$294
- nanoLOCK-L$124
- iFuse Implant$118
- Kerendia$106
How this compares
$9,425 in reported general payments places this provider in the 65th percentile of 446 neurological surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $488 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $445 |
| CefuroximeCefuroxime Axetil | 21 | $298 |
| Gabapentin | 36 | $294 |
| Oxycodone Hcl | 16 | $261 |
| Cyclobenzaprine Hcl | 35 | $258 |
| Pregabalin | 11 | $193 |
| Tramadol Hcl | 11 | $29 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Syracuse
- Ali HazamaSyracuse$83K
- Ryan DenhaeseWilliamsville$1.9M
- J MoccoNew York$1.6M
- Adnan SiddiquiWilliamsville$1.5M
- Leo HopkinsBuffalo$1.2M
- Aziz Basem QandahNew Hartford$1.1M
- Alejandro BerensteinNew York$1.1M
- Darryl LauNew York$915K
- Mark BilskyNew York$903K
- John PollinaWilliamsville$661K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.